Full Press Release Details
Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain.
LXRX
Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain
Key Takeaway: Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain
Price reaction · baseline $0.69 (2025-01-17 close) · hit after-hours · clean, no other LXRX news in the window
day 0 close
+14.2%
day 1
+21.7%
day 3 · peak
+43.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus